ClinConnect ClinConnect Logo
Search / Trial NCT05986799

The Efficacy of Amway Herbal Drink to Improve Skin Anti-aging

Launched by AMWAY (CHINA) R&D CENTER · Aug 3, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Anti Aging Amway Herbal Drink

ClinConnect Summary

This clinical trial is studying whether a herbal drink from Amway can help improve signs of aging in the skin, such as sagging and wrinkles, in healthy middle-aged adults between the ages of 30 and 60. The research will involve 30 participants who will be randomly placed into two groups: one group will drink the Amway herbal drink, while the other will receive a placebo drink (which looks and tastes the same but has no active ingredients). Over a period of three months, participants will make up to four visits to the study center, where their skin's elasticity and appearance will be measured.

To be eligible for this trial, participants need to be healthy adults aged 30 to 60, and they should not be using any other skin products or supplements that might affect the study results. They also need to agree not to engage in certain activities, like cosmetic procedures, during the trial. This study is important because it aims to find out if the herbal drink can significantly benefit skin health, which could be a valuable option for those looking to reduce signs of aging.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male and female subjects, aged 30 to 60 years, with a gender ratio of 3:7;
  • Subjects are healthy;
  • Visual assessment, smoothness is greater than or equal to 3 points (according to the Test Method of Efficacy Measurement of Nourishing Cosmetic Products issued by Chinese Association of Fragrance Flavor and Cosmetic Industries, the smaller the index, the better. Please refer to appendix II);
  • Visual assessment, the gloss index is greater than or equal to 4 points (according to the Unilever Radiance Scale, the smaller the index is the better. Please refer to appendix III);
  • Subjects could not use facial whitening and moisturizing products during the trial;
  • Agree not to take other oral products with similar efficacy (such as collagen, sodium hyaluronate, etc.) during the trial. During the trial, participants agreed not to take any drugs or supplements. Do not do any medical beauty projects during the trial, do not participate in other interventional clinical research;
  • Have a full understanding of the purpose, benefits, and possible risks and side effects of the study;
  • Willing to comply with all research requirements and procedures;
  • Understand the test procedure, read, and sign an appropriate Informed Consent Form indicating their willingness to participate.
  • Exclusion Criteria:
  • Use of any medications or supplements that may alter skin properties during the first 3 months of enrollment;
  • Skin disease patients;
  • Ggastrointestinal symptoms being treated;
  • Lactose intolerance, allergy to fish and its products;
  • Present with other organic diseases that affect intestinal function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, congenital megacolon, scleroderma, anorexia nervosa, etc.;
  • Controlling diet, exercising more, or taking medications to control weight or affect appetite in the last 3 months;
  • Subjects have any of the following medical history or clinical findings that may affect the evaluation of the trial effect: significant gastrointestinal disorders, liver, kidney, endocrine, hematological, respiratory and cardiovascular diseases;
  • Abuse of alcohol or other illicit drugs, supplements currently or in the past, or OTC prescription drugs that may cause intestinal dysfunction or interfere with the evaluation of trial effects;
  • Frequent use of drugs that may affect gastrointestinal function or the immune system, as judged by the researcher;
  • Use of laxatives or other digestive substances in the 2 weeks prior to trial commencement;
  • Women who are pregnant or breastfeeding, or who plan to become pregnant during the trial;
  • PI considers that volunteers cannot fully cooperate with the trial arrangement.

About Amway (China) R&D Center

Amway (China) R&D Center is a leading innovator in health and wellness solutions, dedicated to advancing research and development in dietary supplements and personal care products. With a robust commitment to scientific excellence, the center integrates cutting-edge technologies and methodologies to conduct rigorous clinical trials aimed at enhancing product efficacy and safety. By leveraging a team of experienced researchers and industry experts, Amway (China) R&D Center strives to deliver high-quality, evidence-based products that meet the evolving needs of consumers while adhering to the highest regulatory standards.

Locations

Jinhua, Zhejiang, China

Patients applied

0 patients applied

Trial Officials

Yun Wang, MD

Principal Investigator

Shanghai Jiao Tong University School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported